KBC Group’s Genomic Health, Inc. GHDX Stock Holding History

KBC Group’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-98,653	Closed	-$6.69M	–	1579
2019 Q3	$6.69M	Sell	98,653 -32,865	-25%	-$2.26M	0.05%	390
2019 Q2	$7.65M	Buy	131,518 +40,299	+44%	+$2.39M	0.06%	357
2019 Q1	$6.39M	Buy	+91,219	New	+$6.76M	0.05%	382
2015 Q3	–	Sell	-7,336	Closed	-$204K	–	1399
2015 Q2	$204K	Sell	7,336 -10,733	-59%	-$303K	﹤0.01%	1124
2015 Q1	$552K	Sell	18,069 -927	-5%	-$29.5K	0.01%	874
2014 Q4	$607K	Buy	+18,996	New	+$618K	0.01%	911

KBC Group's GHDX Position: Q4 2019 in Review

KBC Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 98,653 shares — an estimated $6.69M sold.

KBC Group first reported a position in GHDX in Q4 2014 and held it in 6 quarters. The position peaked at $7.65M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

KBC Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
KBC Group sold 98,653 Genomic Health, Inc. shares in Q4 2019, an estimated $6.69M.
KBC Group first reported a position in Genomic Health, Inc. in Q4 2014 and held it in 6 quarters.
KBC Group's Genomic Health, Inc. position peaked at $7.65M in Q2 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on KBC Group's 13F filing for Q4 2019, filed 11 Feb 2020.